Open original FDA record ↗Recall record
- FDA identifier
- Z-1532-2013
- Company in FDA record
- Embla System Llc
- FDA classification date
- Jun 11, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Calibration error for Embla Embletta Gold units calibrated through service center between June 15, 2012 to February 27, 2013. This calibration error could cause a clinician to over titrate the patient and prescribe a therapy pressure higher than is necessary.
Source facts
- Action
- The firm, Embla Systems, LLC, sent an "URGENT: MEDICAL DEVICE RECALL" letter on April 24, 2013, to their customers via courier. The letter described the product, problem and actions to be taken. The customers were instructed to return all recalled units for recalibration and to contact Technical Support at 1-888-662-7632, option #1, at your earliest convenience; Reference the EBG Field Corrective Action in order to obtain your return number. Embla will provide overnight shipping both ways and a three business day turn around for affected units. If you have transferred any of these products to another location, please forward a copy of this urgent notification to that location and notify Manager, Quality and Regulatory Affairs, at 613-254-8877 ext 1105 or via email at EBGFieldCorrectionProgram@natus.com.
- Initiated
- 2013-04-24
- Root cause
- Nonconforming Material/Component
- Terminated
- 2017-03-07
- Distribution
- Worldwide distribution: US (nationwide) including states of: CO, AK, WA, CA, WI, MI, MA OH, DE, FL CA, CT, TX, IL, GA, PA, AZ, DC, VA, MD, UT, IN, MO, NY, NC, OR, NV, NJ, NH, DE, and country of: Canada.
- Recall number
- Z-1532-2013
- Recall status
- Terminated
- CDRH record ID
- 118116
- FDA classified
- 2013-06-11
- Recall event number
- 65175